The RNA N6-Methyladenosine Demethylase FTO Promotes Head and Neck Squamous Cell Carcinoma Proliferation and Migration by Increasing CTNNB1
Yu Zhang,Lixiao Chen,Xiaoliang Wu,Zhenfeng Sun,Fei Wang,Baoxin Wang,Pin Dong
DOI: https://doi.org/10.2147/IJGM.S339095
IF: 2.145
2021-11-24
International Journal of General Medicine
Abstract:Yu Zhang, 1 Lixiao Chen, 1 Xiaoliang Wu, 2 Zhenfeng Sun, 1 Fei Wang, 1 Baoxin Wang, 1 Pin Dong 1 1 Department of Otolaryngology, Head and Neck Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China; 2 Tailai Bioscience, Shenzhen, People's Republic of China Correspondence: Pin Dong Department of Otolaryngology, Head and Neck Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No. 85 Wujin Road, Hongkou District, Shanghai, 200080, People's Republic of China Email Objective: In this study, we aimed to investigate the role of RNA N6-methyladenosine demethylase fat mass and obesity-associated protein ( FTO ) in head and neck squamous cell carcinoma (HNSCC). Methods: Clinical data downloaded from The Cancer Genome Atlas (TCGA) database were used to analyze the relationship between mRNA levels of FTO, METTL3, METTL14 , and ALKBH5 , and the overall survival in cancer and para-cancer datasets. FTO expression in tumor and normal tissues was compared using immunohistochemistry, and its relationship with overall survival was analyzed based on the Kaplan–Meier method. The FaDu cell line with high FTO levels was chosen from five HNSCC cell lines for further experiments. FTO was verified as an oncogene in HNSCC by in vitro loss-of-function and overexpression studies, cell proliferation assay, wound healing assay, and identification of expression changes of epithelial–mesenchymal transition (EMT)-related markers. Catenin beta 1 ( CTNNB1 ) was confirmed as a downstream target gene of FTO with additional methods like the GEPIA online tool, qRT-PCR, Western blotting, and dot blot assay. Results: We found that FTO expression was significantly upregulated in HNSCC datasets and tissues. Increased FTO expression indicated a trend towards poor prognosis and was found to promote disease proliferation and migration. Mechanistically, cell proliferation assay, wound healing assay, and identification of expression changes of EMT-related markers demonstrated that FTO could act as an oncogene in HNSCC. FTO expression was significantly correlated with CTNNB1 expression. Moreover, it exerted a tumorigenic effect by increasing CTNNB1 expression in an m 6 A-dependent manner. Conclusion: FTO promotes head and neck squamous cell carcinoma proliferation and migration by increasing CTNNB1 in an m 6 A-dependent manner. Keywords: FTO , m 6 A, HNSCC, CTNNB1 Head and neck squamous cell carcinoma (HNSCC) is the sixth most common type of malignant tumor in the world, with approximately 600,000 newly diagnosed cases per year. The reason for its high mortality is HNSCC recurrence and metastasis, and most patients are diagnosed with HNSCC at an advanced stage. 1,2 Therefore, exploring the molecular mechanisms regulating HNSCC recurrence and metastasis is likely to be of great significance for improving patient prognosis. N6-methyladenosine (m 6 A) modification, which is methylation at the nitrogen-6 position of adenosine bases in mRNA, is reversible and occurs widely (>25%) as a post-transcriptional modification of mRNA in eukaryotes. 3 This modification has an important role in regulating RNA transactions, including RNA splicing, stability, transport, and translation. 4–7 The m 6 A modification is mainly mediated by the "writers" methyltransferase-like ( METTL3/14 ), 8–10 Wilms tumor 1-associated protein (WTAP), 11 RNA binding motif protein 15/15B (RBM15/15B), 12 and KIAA1429, 13 whereas "erasers" include fat mass and obesity-associated ( FTO ) 14 and alkB homolog 5 (ALKBH5). 15 "Readers" that recognize m 6 A methylated transcripts include YTH domain family proteins (YTHDF1-3, YTHDC1-2), heterogeneous nuclear ribonucleoprotein (HNRNP), and IGF2 mRNA binding proteins (IGF2BPs). 16,17 The m 6 A modification was proven to regulate the occurrence and development of various cancers and was found to play an important role in stem cell differentiation and embryonic development. 4,5 To date, some studies have showed that the alterations of m 6 A on specific RNA sites in HNSCC and several m 6 A regulatory genes could influence the tumorigenesis and act as prognostic biomarkers. 18,19 Positive correlation was found between selected RNA methylation machinery gene expression and m6A abundance on total RNA. 20</su -Abstract Truncated-